EULAR 对疑似进展为类风湿关节炎的关节痛的定义
EULAR 工作组通过三轮 Delphi 法和多中心验证,建立了临床疑似关节痛(CSA)的 7 项参数定义,用于识别有进展为类风湿关节炎风险的关节痛患者。该组合参数在验证队列中识别专家判定为 CSA 患者的 AUC 为 0.92(95% CI 0.87–0.96)。
要点
- CSA 定义包含 7 项参数:症状<1年、MCP 受累、晨僵≥60分钟、晨起最重、一级亲属 RA、握拳困难、MCP 挤压试验阳性。
- 该组合识别专家判定 CSA 的 AUC 为 0.92(95% CI 0.87–0.96)。
- 定义用于临床识别有 RA 进展风险的关节痛患者,非诊断标准。
核心结论
- EULAR 建立了用于识别有进展为 RA 风险的关节痛患者的临床特征组合,即临床疑似关节痛(CSA)定义。
研究设计与样本
- 工作组由 18 名风湿科医生、1 名方法学家、2 名患者、3 名健康专业人员和 1 名研究员组成,分三阶段进行。
- 第一阶段通过三轮 Delphi 法从 55 项参数中筛选出 16 项最重要参数。
- 第二阶段由专家对 50 例现有患者进行纸质评估分类为 CSA/非 CSA 并标注信心水平,推导临时参数集。
- 第三阶段由所有风湿科医生在门诊收集有和无 CSA 的患者进行验证。
主要发现
- 综合参数列表包含 55 项参数,其中 16 项被认为最重要。
- 基于第二阶段数据的多变量模型识别出 7 项相关参数:症状持续时间<1年、掌指关节(MCP)症状、晨僵持续时间≥60分钟、症状在清晨最重、一级亲属患有 RA、握拳困难、MCP 关节挤压试验阳性。
- 第三阶段中该参数组合识别专家认为有 RA 进展风险的关节痛患者准确,受试者工作特征曲线下面积(AUC)为 0.92(95% CI 0.87 至 0.96)。
- 确定了不同截断点的检验特征。
关键数值与推荐
- CSA 相关参数共 7 项:症状持续时间<1年、MCP 关节症状、晨僵持续时间≥60分钟、症状在清晨最重、一级亲属患有 RA、握拳困难、MCP 关节挤压试验阳性。
- 该 7 项参数组合识别专家判定 CSA 的 AUC 为 0.92(95% CI 0.87 至 0.96)。
临床怎么用
- 风湿免疫科医生可依据 7 项 CSA 参数识别有进展为 RA 风险的关节痛患者,便于早期监测和随访。
- 该定义为专家共识性临床特征组合,不是 RA 诊断标准,需结合临床判断使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: During the transition to rheumatoid arthritis (RA) many patients pass through a phase characterised by the presence of symptoms without clinically apparent synovitis. These symptoms are not well-characterised. This taskforce aimed to define the clinical characteristics of patients with arthralgia who are considered at risk for RA by experts based on their clinical experience. METHODS: The taskforce consisted of 18 rheumatologists, 1 methodologist, 2 patients, 3 health professionals and 1 research fellow. The process had three phases. In phase I, a list of parameters considered characteristic for clinically suspect arthralgia (CSA) was derived; the most important parameters were selected by a three-phased Delphi approach. In phase II, the experts evaluated 50 existing patients on paper, classified them as CSA/no-CSA and indicated their level of confidence. A provisional set of parameters was derived. This was studied for validation in phase III, where all rheumatologists collected patients with and without CSA from their outpatient clinics. RESULTS: The comprehensive list consisted of 55 parameters, of which 16 were considered most important. A multivariable model based on the data from phase II identified seven relevant parameters: symptom duration <1 year, symptoms of metacarpophalangeal (MCP) joints, morning stiffness duration ≥60 min, most severe symptoms in early morning, first-degree relative with RA, difficulty with making a fist and positive squeeze test of MCP joints. In phase III, the combination of these parameters was accurate in identifying patients with arthralgia who were considered at risk of developing RA (area under the receiver operating characteristic curve 0.92, 95% CI 0.87 to 0.96). Test characteristics for different cut-off points were determined. CONCLUSIONS: A set of clinical characteristics for patients with arthralgia who are at risk of progression to RA was established.
引用
- van Steenbergen HW, Aletaha D, Beaart-van de Voorde LJ, et al. EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis. Ann Rheum Dis. 2016. PMID: 27991858. doi:10.1136/annrheumdis-2016-209846
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。